13F Holdings
中文EN

CBUS Cibus, Inc.

Agricultural Chemicals · Nasdaq · SEC CIK 1705843 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY19.5%
TTM net income YoY18.8%
TTM EPS YoY46.1%
Revenue 3-yr CAGR81.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-1,326.7%
Net margin-2,131.4%
FCF margin-966.0%
EBITDA margin-1,243.0%

Returns

ROE-431.9%
ROA-30.6%
ROIC (approx.)-826.6%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets101.9%
Debt / equity—
Current ratio0.95x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.45x
Accruals ratio-16.8%
Payout ratio—
Capex / revenue3.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$3.64M$4.26M$1.82M$157,000$25.99M
Cost of revenue———$0$28.56M
Gross profit———$157,000-$2.57M
R&D expense$44.20M$50.43M$42.37M$11.55M$11.34M
SG&A expense$26.91M$30.80M$28.91M$10.97M—
Operating income-$97.53M-$258.40M-$318.88M-$22.37M-$29.33M
Interest expense———$75,000$1.43M
Pretax income-$132.17M-$282.68M-$337.64M-$16.89M-$29.20M
Income tax$29,000$29,000-$4,000$0$0
Net income-$127.08M-$251.39M-$267.63M-$16.89M-$29.20M
EBITDA-$91.61M-$251.54M-$314.19M-$20.84M-$26.99M
EPS (basic)-2.78-10.83-25.95-18.36-0.78
EPS (diluted)-2.78-10.83-25.95-18.36-0.78
Weighted avg. shares (diluted)45.76M23.22M10.31M919,95937.48M
Balance sheet
Cash & equivalents$9.92M$14.43M$32.70M$3.53M$14.42M
Short-term investments———$0$0
Receivables$503,000$1.04M$530,000$0$0
Inventory————$0
Current assets$12.07M$16.95M$35.22M$4.13M$15.18M
PP&E, net$6.30M$11.44M$15.78M$4.52M$21.73M
Goodwill$232.52M$253.47M$434.90M$0—
Intangibles$31.68M$33.58M$35.41M$158,000—
Total assets$305.05M$350.07M$544.41M$22.42M$37.19M
Current liabilities$16.86M$19.88M$21.32M$1.66M$4.85M
Short-term debt$435,000$436,000$833,000$0—
Long-term debt$93,000$226,000$536,000$0$0
Total debt$528,000$662,000$1.37M$0$0
Total liabilities$283.22M$252.24M$206.12M$15.19M$23.06M
Shareholders' equity$21.83M$92.16M$293.47M$7.23M$14.13M
Net debt-$9.39M-$13.77M-$31.33M-$3.53M-$14.42M
Shares outstanding—29.66M23.71M4.88M38.77M
Cash flow statement
Operating cash flow-$50.59M-$58.04M-$46.21M-$19.36M-$18.81M
Capital expenditure$578,000$808,000$4.32M$1.52M$497,000
Free cash flow-$51.17M-$58.85M-$50.53M-$20.88M-$19.31M
Investing cash flow-$578,000-$808,000$55.06M-$1.52M$11.20M
Financing cash flow$46.65M$40.60M$20.32M$9.99M$3.74M
Depreciation & amortization$5.92M$6.86M$4.69M$1.53M$2.34M
Stock-based compensation$8.19M$10.75M$16.09M$4.00M$2.09M

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.